COMMUNIQUÉS West-GlobeNewswire

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/09/2025
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases ( [...]
Interim results for the six months ended June 30, 2025
12/09/2025
September 12, 2025 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2025 Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company [...]
FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells' Therapeutic Advantages Over Traditional Stem Cell Therapies
12/09/2025
HOUSTON, Sept. 12, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
12/09/2025
1 st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR 1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 – $100 million Prenetics [...]
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/09/2025
JENA, Germany, Sept. 12, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system (the “Company”), today announced [...]
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
12/09/2025
Dr. Barbara Klencke is an accomplished clinical leader with a distinguished track record in oncology drug development who currently serves on the Company’s Board of Directors and will step down from the Board to join [...]
Anosh Inc Foundation, Led by Anosh Ahmed, Aims to Deliver 100,000 Free Meals in Dubai and Pakistan
12/09/2025
Building on its Ramadan campaign, the foundation expands food relief efforts to reach vulnerable communities year-round. Philanthropist Anosh Ahmed with meals to be distributed in Dubai and Pakistan. DUBAI, United Arab [...]
24/7 Market News: Kraig Labs Positioned at the Forefront of the Next-Gen Materials Revolution
12/09/2025
Spider Silk: The Breakthrough Material Powering the Future of Wearable Tech DENVER, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial [...]
Mise à jour de l’information relative à l’Assemblée Générale du 30 septembre 2025-Constitution d’un pacte réunissant 61 actionnaires fondateurs, historiques, salariés et dirigeants de la Société portant sur environ 20,1% des droits de vote
12/09/2025
Mise à jour de l’information relative à l’Assemblée Générale du 30 septembre 2025 Constitution d’un pacte réunissant 61 actionnaires fondateurs, historiques, salariés et dirigeants de la Société portant sur environ 20,1 [...]
Update on Information Relating to the General Meeting of September 30, 2025
12/09/2025
Update on Information Relating to the General Meeting of September 30, 2025 61 Founding, Historical, Employee and Executive Shareholders of the Company, Representing Approximately 20.1% of Voting Rights have entered [...]
Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025
12/09/2025
— HUTCHMED will host in-person presentation and online webinar on Friday, October 31 — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 12, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/ [...]
Global Pioneer: KFSHRC Showcases Robotic Organ Transplantation Leadership at C3 Davos of Healthcare™ New York Summit
11/09/2025
NEW YORK, Sept. 11, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has reinforced its position as a global pioneer in organ transplantation, marked by the world’s first fully [...]
Pennant Group to Participate in the 2025 Jefferies Healthcare Services Conference
11/09/2025
EAGLE, Idaho, Sept. 11, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Recludix Pharma to Present at the Stifel 2025 Virtual Immunology and Inflammation Forum
11/09/2025
SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in the discovery of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief [...]
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
11/09/2025
Company announcement – No. 20 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 11, 2025 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: [...]
Actuate Therapeutics Announces Closing of $17.25 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option
11/09/2025
CHICAGO and FORT WORTH, Texas, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for [...]
Kestra Medical Technologies Reports First Quarter Fiscal 2026 Financial Results
11/09/2025
KIRKLAND, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the first quarter [...]
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
11/09/2025
BOSTON and SAN DIEGO, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/09/2025
NEW YORK and WALTHAM, Mass., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]

Pages